Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma

Zymeworks appointed Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma, effective immediately. She will lead commercial strategy and execution for YUPELRI (revefenacin), the once-daily nebulized LAMA for COPD, following Zymeworks' recent acquisition of Theravance Biopharma, reporting to Chair and CEO Kenneth Galbraith. Monahan brings 20+ years of commercial experience, most recently as SVP at Pacira BioSciences, with prior roles at Shionogi, Circassia, Salix, and Sanofi-Aventis spanning respiratory, hospital, and specialty markets.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.